UA102261C2 - Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide - Google Patents

Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Info

Publication number
UA102261C2
UA102261C2 UAA201102840A UAA201102840A UA102261C2 UA 102261 C2 UA102261 C2 UA 102261C2 UA A201102840 A UAA201102840 A UA A201102840A UA A201102840 A UAA201102840 A UA A201102840A UA 102261 C2 UA102261 C2 UA 102261C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical compositions
oxoquinoline
dimethylethyl
carboxamide
hydroxyphenyl
Prior art date
Application number
UAA201102840A
Other languages
Russian (ru)
Inventor
Уилльям Роу
Патрисия Хертер
Кристофер Янг
Кирк Дайнхарт
Маринус Якобус Вервейс
Кирк Оверхофф
Петер Д. Й. Гротенхейс
Мартин Ботфилд
Альфредо Гросси
Original Assignee
Вертекс Фармасьютикалз Инкорпорейтед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вертекс Фармасьютикалз Инкорпорейтед filed Critical Вертекс Фармасьютикалз Инкорпорейтед
Priority claimed from PCT/US2009/004629 external-priority patent/WO2010019239A2/en
Publication of UA102261C2 publication Critical patent/UA102261C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
UAA201102840A 2008-08-13 2009-08-13 Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide UA102261C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8870408P 2008-08-13 2008-08-13
PCT/US2009/004629 WO2010019239A2 (en) 2008-08-13 2009-08-13 Pharmaceutical composition and administrations thereof

Publications (1)

Publication Number Publication Date
UA102261C2 true UA102261C2 (en) 2013-06-25

Family

ID=51947652

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201102840A UA102261C2 (en) 2008-08-13 2009-08-13 Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Country Status (1)

Country Link
UA (1) UA102261C2 (en)

Similar Documents

Publication Publication Date Title
MX2011001782A (en) Pharmaceutical composition and administrations thereof.
MX2012001939A (en) Pharmaceutical composition and administrations thereof.
ME03786B (en) Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
IL265430A (en) Pharmaceutical compositions containing a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamode and uses thereof
HK1129581A1 (en)
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
MX2010002974A (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4 -dihydro-4-oxoquinoline-3-carboxamide.
MX2010008138A (en) Pharmaceutical dosage form.
EP2687287A3 (en) Delivery particles
EP2687590A3 (en) Delivery particles
PH12013502192A1 (en) Antibodies against human angiopoietin 2
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2010122332A3 (en) Xanthan gum and swellable particulate containing composition and uses thereof
WO2009125409A3 (en) Fatty acid amides and uses thereof
MY148915A (en) An extended-release composition comprising a somatostatin derivative in microparticles
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
WO2012010638A3 (en) Luminescent impression material
UA103996C2 (en) Ivabradine hydrobromide
UA102261C2 (en) Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
TNSN08442A1 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same